Digoxin, a drug derived from the foxglove plant, is one of the oldest and most widely used treatments for a variety of cardiac conditions. For example, it can regularize the heartbeat in many who have ...

LONDON, UK — The use of digoxin was associated with a slightly improved survival but no difference in rate of rehospitalization in a new study based on a nationwide propensity-matched cohort of Danish ...

Digoxin now deserves to be considered first-line therapy for long-term heart rate control in older patients with permanent atrial fibrillation and symptoms of heart failure, investigators on a new ...

Digoxin, a drug commonly used to treat heart conditions, was associated with a 72 percent higher rate of death among adults with newly diagnosed systolic heart failure. Digoxin, a drug commonly used ...

UB researchers have identified for the first time an enzyme in the foxglove plant that is responsible for the production of compounds needed to make the heart failure drug digoxin. The breakthrough ...

AHA: Increased Cancer Risk for Patients With Heart Failure Incident digoxin use was linked with higher rates of death and heart failure hospitalization. James V. Freeman, MD, of Stanford University in ...

At present, digoxin should not be recommended for the treatment of patients with mild-to-moderate diastolic HF with preserved LVEF of greater than 45% in sinus rhythm This was an ancillary study ...

Digoxin was shown to be dangerous at high levels for atrial fibrillation (Afib) patients in a randomized trial. Meanwhile, another study suggested the benefit of genotyping for better warfarin ...

To the Editor: The report by Rathore et al. (Oct. 31 issue) 1 emphasizes differences according to sex in the outcomes of digoxin therapy in patients with congestive heart failure. Their post hoc ...

The DIG trial showed that digoxin reduced heart-failure (HF)-related hospitalizations, but not overall mortality, in HF patients with ejection fraction (EF) ≤45%. Low serum digoxin concentrations ...

(HealthDay News) — Only 1 in 5 patients with heart failure with reduced ejection fraction (HFrEF) receive digoxin at discharge, according to a study published online in JACC: Heart Failure. Nish Patel ...

A potentially life threatening label mistake caused Marlex Pharmaceuticals to recall two lots of heart failure medication Digoxin. Here’s what you need to know. What Digoxin tablets are recalled?